Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethylene Glycol SCHEMBL8944566 | 0.93 | CYP2C9 (0.37) | CYP2C9 | |
| Adamantan-2-Ol SCHEMBL1150618 | 0.80 | CYP2C9 (0.62) | CYP2C9 | |
| SCHEMBL18084058 | 0.75 | — | — | |
| SCHEMBL28133082 | 0.75 | CYP2C9 (0.42) | CYP2C9 | |
| SCHEMBL11334523 | 0.75 | TSHR (0.33) | — | |
| SCHEMBL5095125 | 0.75 | HSD11B1 (0.34) | — | |
| SCHEMBL5093293 | 0.73 | — | — | |
| SCHEMBL6346851 | 0.71 | — | — | |
| SCHEMBL332860 | 0.71 | — | — | |
| SCHEMBL9150172 | 0.70 | HSD11B1 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5410092-A | Synthesis of adamantane-2,4-dione | MOBIL OIL CORPORATION (US) | 1995-04-25 | — | — | US | claimed |
| US-5298666-A | Synthesis of adamantane-2,4-dione | MOBIL OIL CORPORATION (US) | 1994-03-29 | — | — | US | claimed |
| CN-119241440-A | Indazole benzoic acid derivative containing urea structure and preparation method and application thereof | 沈阳药科大学 | 2025-01-03 | — | — | CN | disclosed |
| CN-116947740-A | Hydroxamic acid compound containing urea structure, preparation method thereof and application of hydroxamic acid compound in preparation of HDAC and sEH dual inhibitors | 沈阳药科大学 | 2023-10-27 | — | — | CN | disclosed |
| US-9513545-B2 | Homoadamantane derivatives, process for preparing same, and photoresist compositions | OSAKA ORGANIC CHEMICAL INDUSTRY LTD. (JP) | 2016-12-06 | — | — | US | disclosed |
| EP-2433972-B1 | Polymer compound, photoresist composition containing such polymer compound, and method for forming resist pattern | TOKYO OHKA KOGYO CO LTD (JP) | 2014-11-12 | — | — | EP | disclosed |
| EP-1717261-B1 | POLYMER COMPOUND, PHOTORESIST COMPOSITION CONTAINING SUCH POLYMER COMPOUND, AND METHOD FOR FORMING RESIST PATTERN | TOKYO OHKA KOGYO CO LTD (JP) | 2014-01-01 | — | — | EP | disclosed |
| US-20130143157-A1 | HOMOADAMANTANE DERIVATIVES, PROCESS FOR PREPARING SAME, AND PHOTORESIST COMPOSITIONS | IDEMITSU KOSAN CO., LTD. (JP) | 2013-06-06 | — | — | US | disclosed |
| EP-2433972-A1 | Polymer compound, photoresist composition containing such polymer compound, and method for forming resist pattern | Tokyo Ohka Kogyo Co., Ltd. (JP) | 2012-03-28 | — | — | EP | disclosed |
| US-8110614-B2 | Adamantane derivative, method for producing the same, and resin composition containing adamantane derivative | IDEMITSU KOSAN CO., LTD. (JP) | 2012-02-07 | — | — | US | disclosed |
| US-8084650-B2 | Adamantane derivative, resin composition containing same, and optoelectronic member and sealing agent for electronic circuit using those | IDEMITSU KOSAN CO., LTD. (JP) | 2011-12-27 | — | — | US | disclosed |
| EP-1577285-A1 | ADAMANTANE DERIVATIVE AND PROCESS FOR PRODUCING THE SAME | IDEMITSU KOSAN COMPANY LIMITED (JP) | 2005-09-21 | — | — | EP | disclosed |
| US-20050004391-A1 | Adamantyl vinyl ether compound and production process for the same | IDEMITSU PETROCHEMICAL CO., LTD. (JP) | 2005-01-06 | — | — | US | disclosed |
| EP-1486480-A1 | Adamantyl vinyl ether compound and production process for the same | Idemitsu Petrochemical Co., Ltd. (JP) | 2004-12-15 | — | — | EP | disclosed |
| EP-0661271-B1 | AZEPINE DERIVATIVES, PRODUCTION THEREOF, AND USE THEREOF AS SIGMA-RECEPTOR LIGANDS | ASAHI CHEMICAL IND (JP) | 2000-04-26 | — | — | EP | disclosed |
| US-5658923-A | USED IN TREATING DISEASES RELATED TO SIGMA-RECEPTOR, SUCH AS SCHIZOPHRENIA | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1997-08-19 | — | — | US | disclosed |
| EP-0661271-A1 | AZEPINE DERIVATIVE, PRODUCTION THEREOF, AND USE THEREOF | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1995-07-05 | — | — | EP | disclosed |
| US-5430193-A | Synthesis of 4-hydroxy-2-adamantanes and related compounds | MOBIL OIL CORPORATION (US) | 1995-07-04 | — | — | US | disclosed |
| US-5410092-A | Synthesis of adamantane-2,4-dione | MOBIL OIL CORPORATION (US) | 1995-04-25 | — | — | US | disclosed |
| US-5298666-A | Synthesis of adamantane-2,4-dione | MOBIL OIL CORPORATION (US) | 1994-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050004391-A1 | Adamantyl vinyl ether compound and production process for the same | NOTUM, CYP4A11, CYP4F11 | CYP2C9 214/4885 |
| US-20130143157-A1 | HOMOADAMANTANE DERIVATIVES, PROCESS FOR PREPARING SAME, AND PHOTORESIST COMPOSITIONS | CRY1, CYP4A11, FTO | CYP2C9 179/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.